ClinicalTrials.Veeva

Menu

Middle Cerebral Artery Acceleration Time as Indicator in Fetal Anemia

A

Assiut University

Status

Not yet enrolling

Conditions

Fetal Anemia

Study type

Observational

Funder types

Other

Identifiers

NCT07409961
AUOBG052026

Details and patient eligibility

About

Fetal anemia one of serious fetal problems that may lead in sever cases to fetal demise early detection and precise intervention safe fetal life , traditional evaluation the severity and need of blood transfusion done by middle cerebral artery peak systolic velocity in doppler wave, in this study innovative technique suggested to compared with standard technique

Enrollment

20 estimated patients

Sex

Female

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • fetus with fetal anemia or hyperdynamic state

Exclusion criteria

  • associated fetal congenital anomalies

Trial contacts and locations

0

Loading...

Central trial contact

Sief Ali

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems